Laurent Jespers
InvestorEntrepreneur in Residence (EIR) at Cambridge Innovation Capital
About
Laurent Jespers has around 25 years of experience in discovery and early-stage clinical development across multiple therapeutic modalities and disease areas. He previously served as Chief Scientific Officer at Xap Therapeutics, held a Vice President role in Biopharmaceuticals and Cell & Gene Therapy at GSK, and was an early employee at Domantis Ltd (later acquired by GSK). He holds an MSc in Chemistry and a PhD in Biochemistry from the University of Leuven, Belgium, and is an alumnus of the MRC Laboratory of Molecular Biology.
Invests in
Biotech
Colleagues at Cambridge Innovation Capital
Adam Glinsman
Investor at Cambridge Innovation Capital
Andrew Williamson
Managing Partner at Cambridge Innovation Capital
Andy Neely
Vice Chair at Cambridge Innovation Capital
Andy Richards
Investor at Cambridge Innovation Capital
Anne Horgan
Partner at Cambridge Innovation Capital
Christopher Tapper
Senior Associate at Cambridge Innovation Capital
Damian Crowther
Entrepreneur in Residence at Cambridge Innovation Capital
Dipesh Patel
Operating Partner at Cambridge Innovation Capital
Frequently asked questions
- Who is Laurent Jespers?
- Laurent Jespers has around 25 years of experience in discovery and early-stage clinical development across multiple therapeutic modalities and disease areas. He previously served as Chief Scientific Officer at Xap Therapeutics, held a Vice President role in Biopharmaceuticals and Cell & Gene Therapy at GSK, and was an early employee at Domantis Ltd (later acquired by GSK). He holds an MSc in Chemistry and a PhD in Biochemistry from the University of Leuven, Belgium, and is an alumnus of the MRC Laboratory of Molecular Biology.
- Where does Laurent Jespers work?
- Laurent Jespers is Entrepreneur in Residence (EIR) at Cambridge Innovation Capital.
- What does Laurent Jespers invest in?
- Laurent Jespers invests in Biotech.